{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:50:39Z","timestamp":1787003439989,"version":"build-2736575974"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T00:00:00Z","timestamp":1619740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T00:00:00Z","timestamp":1619740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Korea Centers for Disease Control and Prevention.","award":["2016-ER6304-02"],"award-info":[{"award-number":["2016-ER6304-02"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>We investigated the effects of stent generation on 2-year clinical outcomes between prediabetes and diabetes patients after acute myocardial infarction (AMI). A total of 13,895 AMI patients were classified into normoglycemia (group A: 3673), prediabetes (group B: 5205), and diabetes (group C: 5017). Thereafter, all three groups were further divided into first-generation (1G)-drug-eluting stent (DES) and second-generation (2G)-DES groups. Patient-oriented composite outcomes (POCOs) defined as all-cause death, recurrent myocardial infarction (Re-MI), and any repeat revascularization were the primary outcome. Stent thrombosis (ST) was the secondary outcome. In both prediabetes and diabetes groups, the cumulative incidences of POCOs, any repeat revascularization, and ST were higher in the 1G-DES than that in the 2G-DES. In the diabetes group, all-cause death and cardiac death rates were higher in the 1G-DES than that in the 2G-DES. In both stent generations, the cumulative incidence of POCOs was similar between the prediabetes and diabetes groups. However, in the 2G-DES group, the cumulative incidences of Re-MI and all-cause death or MI were significantly higher in the diabetes group than that in the prediabetes group. To conclude, 2G-DES was more effective than 1G-DES in reducing the primary and secondary outcomes for both prediabetes and diabetes groups.<\/jats:p>","DOI":"10.1038\/s41598-021-88593-x","type":"journal-article","created":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T06:04:45Z","timestamp":1619762685000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Effects of stent generation on clinical outcomes after acute myocardial infarction compared between prediabetes and diabetes patients"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9669-3598","authenticated-orcid":false,"given":"Yong Hoon","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9990-6843","authenticated-orcid":false,"given":"Ae-Young","family":"Her","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2424-810X","authenticated-orcid":false,"given":"Myung Ho","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2493-066X","authenticated-orcid":false,"given":"Byeong-Keuk","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4893-039X","authenticated-orcid":false,"given":"Sung-Jin","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6783-3849","authenticated-orcid":false,"given":"Seunghwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7071-4370","authenticated-orcid":false,"given":"Chul-Min","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2263-3274","authenticated-orcid":false,"given":"Jung-Sun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7748-5788","authenticated-orcid":false,"given":"Young-Guk","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2009-9760","authenticated-orcid":false,"given":"Donghoon","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2090-2031","authenticated-orcid":false,"given":"Myeong-Ki","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2169-3112","authenticated-orcid":false,"given":"Yangsoo","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,30]]},"reference":[{"key":"88593_CR1","doi-asserted-by":"publisher","first-page":"34","DOI":"10.4103\/HEARTVIEWS.HEARTVIEWS_37_17","volume":"18","author":"R Hajar","year":"2017","unstructured":"Hajar, R. Diabetes as \u201ccoronary artery disease risk equivalent\u201d: A historical perspective. Heart Views. 18, 34\u201337 (2017).","journal-title":"Heart Views."},{"key":"88593_CR2","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1093\/eurheartj\/eht108","volume":"34","author":"L Ryd\u00e9n","year":"2013","unstructured":"Ryd\u00e9n, L. et al. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: The Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur. Heart J. 34, 3035\u20133087 (2013).","journal-title":"Eur. Heart J."},{"key":"88593_CR3","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1161\/01.CIR.0000140721.27004.4B","volume":"110","author":"DE Cutlip","year":"2004","unstructured":"Cutlip, D. E. et al. Beyond restenosis: Five-year clinical outcomes from second-generation coronary stent trials. Circulation 110, 1226\u20131230 (2004).","journal-title":"Circulation"},{"key":"88593_CR4","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1001\/jama.293.17.2126","volume":"293","author":"I Iakovou","year":"2005","unstructured":"Iakovou, I. et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293, 2126\u20132130 (2005).","journal-title":"JAMA"},{"key":"88593_CR5","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1016\/j.jcin.2018.09.033","volume":"11","author":"M Konigstein","year":"2018","unstructured":"Konigstein, M. et al. Outcomes among diabetic patients undergoing percutaneous coronary intervention with contemporary drug-eluting stents: Analysis from the BIONICS randomized trial. JACC Cardiovasc. Interv. 11, 2467\u20132476 (2018).","journal-title":"JACC Cardiovasc. Interv."},{"key":"88593_CR6","doi-asserted-by":"publisher","first-page":"e14669","DOI":"10.1097\/MD.0000000000014669","volume":"98","author":"X Zhuo","year":"2019","unstructured":"Zhuo, X. et al. In-hospital, short-term and long-term adverse clinical outcomes observed in patients with type 2 diabetes mellitus vs non-diabetes mellitus following percutaneous coronary intervention: A meta-analysis including 139,774 patients. Medicine 98, e14669 (2019).","journal-title":"Medicine"},{"key":"88593_CR7","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/j.amjcard.2013.01.281","volume":"111","author":"G de Luca","year":"2013","unstructured":"de Luca, G. et al. Meta-analysis comparing efficacy and safety of first generation drug-eluting stents to bare-metal stents in patients with diabetes mellitus undergoing primary percutaneous coronary intervention. Am. J. Cardiol. 111, 1295\u20131304 (2013).","journal-title":"Am. J. Cardiol."},{"key":"88593_CR8","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s12928-017-0458-9","volume":"33","author":"K Nakatsuma","year":"2018","unstructured":"Nakatsuma, K. et al. Second-generation versus first-generation drug-eluting stents in patients with and without diabetes mellitus: Pooled analysis from the RESET and NEXT trials. Cardiovasc. Interv. Ther. 33, 125\u2013134 (2018).","journal-title":"Cardiovasc. Interv. Ther."},{"key":"88593_CR9","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.ijcard.2016.12.116","volume":"230","author":"C Bavishi","year":"2017","unstructured":"Bavishi, C. et al. Efficacy and safety of everolimus and zotarolimus-eluting stents versus first-generation drug-eluting stents in patients with diabetes: A meta-analysis of randomized trials. Int. J. Cardiol. 230, 310\u2013318 (2017).","journal-title":"Int. J. Cardiol."},{"key":"88593_CR10","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.ahj.2012.02.006","volume":"163","author":"E Grube","year":"2012","unstructured":"Grube, E. et al. The SPIRIT V diabetic study: A randomized clinical evaluation of the XIENCE V everolimus-eluting stent vs the TAXUS Liberte paclitaxel-eluting stent in diabetic patients with de novo coronary artery lesions. Am. Heart J. 163, 867\u2013875 (2012).","journal-title":"Am. Heart J."},{"key":"88593_CR11","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s00380-018-1252-z","volume":"34","author":"MJ Hsieh","year":"2019","unstructured":"Hsieh, M. J. et al. Complete and incomplete revascularization in non-ST segment myocardial infarction with multivessel disease: Long-term outcomes of first- and second-generation drug-eluting stents. Heart Vessls. 34, 251\u2013258 (2019).","journal-title":"Heart Vessls."},{"key":"88593_CR12","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.ahj.2014.06.023","volume":"168","author":"SV Arnold","year":"2014","unstructured":"Arnold, S. V. et al. Prevalence of glucose abnormalities among patients presenting with an acute myocardial infarction. Am. Heart J. 168, 466\u2013470 (2014).","journal-title":"Am. Heart J."},{"key":"88593_CR13","doi-asserted-by":"publisher","first-page":"e1049","DOI":"10.4244\/EIJ-D-17-01067","volume":"14","author":"MM Kok","year":"2018","unstructured":"Kok, M. M. et al. Prediabetes and its impact on clinical outcome after coronary intervention in a broad patient population. EuroIntervention 14, e1049\u2013e1056 (2018).","journal-title":"EuroIntervention"},{"key":"88593_CR14","doi-asserted-by":"publisher","first-page":"107994","DOI":"10.1016\/j.diabres.2019.107994","volume":"160","author":"YH Kim","year":"2020","unstructured":"Kim, Y. H. et al. Effects of prediabetes on long-term clinical outcomes of patients with acute myocardial infarction who underwent PCI using new-generation drug-eluting stents. Diabetes Res. Clin. Pract. 160, 107994 (2020).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"88593_CR15","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.amjcard.2018.10.032","volume":"123","author":"NW Carris","year":"2019","unstructured":"Carris, N. W. et al. Prevention of diabetes mellitus in patients with prediabetes. Am. J. Cardiol. 123, 507\u2013512 (2019).","journal-title":"Am. J. Cardiol."},{"key":"88593_CR16","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1161\/01.CIR.0000091257.27563.32","volume":"108","author":"MA Creager","year":"2003","unstructured":"Creager, M. A. et al. Diabetes and vascular disease: Pathophysiology, clinical consequences, and medical therapy: Part I. Circulation 108, 1527\u20131532 (2003).","journal-title":"Circulation"},{"key":"88593_CR17","doi-asserted-by":"publisher","first-page":"i5953","DOI":"10.1136\/bmj.i5953","volume":"355","author":"Y Huang","year":"2016","unstructured":"Huang, Y., Cai, X., Mai, W., Li, M. & Hu, Y. Association between prediabetes and risk of cardiovascular disease and all cause mortality: Systematic review and meta-analysis. BMJ 355, i5953 (2016).","journal-title":"BMJ"},{"key":"88593_CR18","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1056\/NEJMoa032441","volume":"350","author":"GW Stone","year":"2004","unstructured":"Stone, G. W. et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N. Engl. J. Med. 350, 221\u2013231 (2004).","journal-title":"N. Engl. J. Med."},{"key":"88593_CR19","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1016\/j.jacc.2009.01.050","volume":"53","author":"G Weisz","year":"2009","unstructured":"Weisz, G. et al. Five-year follow-up after sirolimus-eluting stent implantation results of the SIRIUS (Sirolimus-Eluting Stent in De-Novo Native Coronary Lesions) trial. J. Am. Coll. Cardiol. 53, 1488\u20131497 (2009).","journal-title":"J. Am. Coll. Cardiol."},{"key":"88593_CR20","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1161\/CIRCULATIONAHA.111.031070","volume":"124","author":"GW Stone","year":"2011","unstructured":"Stone, G. W. et al. Differential clinical responses to everolimus-eluting and Paclitaxel-eluting coronary stents in patients with and without diabetes mellitus. Circulation 124, 893\u2013900 (2011).","journal-title":"Circulation"},{"key":"88593_CR21","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1016\/j.amjcard.2012.07.022","volume":"110","author":"LO Jensen","year":"2012","unstructured":"Jensen, L. O. et al. Comparison of outcomes in patients with versus without diabetes mellitus after revascularization with everolimus- and sirolimus-eluting stents (from the SORT OUT IV trial). Am. J. Cardiol. 110, 1585\u20131591 (2012).","journal-title":"Am. J. Cardiol."},{"key":"88593_CR22","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.jcin.2017.10.038","volume":"11","author":"C von Birgelen","year":"2018","unstructured":"von Birgelen, C. et al. \u201cSilent\u201d diabetes and clinical outcome after treatment with contemporary drug-eluting stents: The BIO-RESORT silent diabetes study. JACC Cardiovasc. Interv. 11, 448\u2013459 (2018).","journal-title":"JACC Cardiovasc. Interv."},{"key":"88593_CR23","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s12928-017-0458-9","volume":"33","author":"Nakatsuma","year":"2018","unstructured":"Nakatsuma, et al. Second-generation versus first-generation drug-eluting stents in patients with and without diabetes mellitus: Pooled analysis from the RESET and NEXT trials. Cardiovasc Interv. Ther. 33, 125\u2013134 (2018).","journal-title":"Cardiovasc Interv. Ther."},{"key":"88593_CR24","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41569-019-0234-x","volume":"17","author":"S Torii","year":"2020","unstructured":"Torii, S. et al. Drug-eluting coronary stents: Insights from preclinical and pathology studies. Nat. Rev. Cardiol. 17, 37\u201351 (2020).","journal-title":"Nat. Rev. Cardiol."},{"key":"88593_CR25","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1093\/eurheartj\/ehr479","volume":"33","author":"G Sarno","year":"2012","unstructured":"Sarno, G. et al. Lower risk of stent thrombosis and restenosis with unrestricted use of \u201cnew-generation\u201d drug-eluting stents: A report from the nationwide Swedish Coronary Angiography and Angioplasty Registry (SCAAR). Eur. Heart J. 33, 606\u2013613 (2012).","journal-title":"Eur. Heart J."},{"key":"88593_CR26","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1016\/j.jacc.2008.12.055","volume":"53","author":"JW van Werkum","year":"2009","unstructured":"van Werkum, J. W. et al. Predictors of coronary stent thrombosis: The Dutch stent thrombosis registry. J. Am. Coll. Cardiol. 53, 1399\u20131409 (2009).","journal-title":"J. Am. Coll. Cardiol."},{"key":"88593_CR27","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jcin.2019.09.033","volume":"13","author":"SJ Hong","year":"2020","unstructured":"Hong, S. J. et al. Effect of intravascular ultrasound-guided drug-eluting stent implantation: 5-year follow-up of the IVUS-XPL randomized trial. JACC Cardiovasc. Interv. 13, 62\u201371 (2020).","journal-title":"JACC Cardiovasc. Interv."},{"key":"88593_CR28","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1056\/NEJMoa0807611","volume":"360","author":"PA Tonino","year":"2009","unstructured":"Tonino, P. A. et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N. Engl. J. Med. 360, 213\u2013224 (2009).","journal-title":"N. Engl. J. Med."},{"key":"88593_CR29","doi-asserted-by":"publisher","first-page":"720","DOI":"10.3349\/ymj.2017.58.4.720","volume":"58","author":"YH Kim","year":"2017","unstructured":"Kim, Y. H. et al. Routine angiographic follow-up versus clinical follow-up after percutaneous coronary intervention in acute myocardial infarction. Yonsei Med. J. 58, 720\u2013730 (2017).","journal-title":"Yonsei Med. J."},{"key":"88593_CR30","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1093\/eurjhf\/hfr009","volume":"13","author":"PC Deedwania","year":"2011","unstructured":"Deedwania, P. C. et al. Impact of diabetes mellitus on outcomes in patients with acute myocardial infarction and systolic heart failure. Eur. J. Heart Fail. 13, 551\u2013559 (2011).","journal-title":"Eur. J. Heart Fail."},{"key":"88593_CR31","doi-asserted-by":"publisher","first-page":"107574","DOI":"10.1016\/j.jdiacomp.2020.107574","volume":"34","author":"YH Kim","year":"2020","unstructured":"Kim, Y. H. et al. Effect of renin-angiotensin system inhibitors on major clinical outcomes in patients with acute myocardial infarction and prediabetes or diabetes after successful implantation of newer-generation drug-eluting stents. J. Diabetes Complications. 34, 107574 (2020).","journal-title":"J. Diabetes Complications."},{"issue":"Suppl 1","key":"88593_CR32","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.2337\/dc10-S011","volume":"33","author":"American Diabetes Association","year":"2010","unstructured":"American Diabetes Association. Standards of medical care in diabetes\u20132010. Diabetes Care 33(Suppl 1), S11-61 (2010).","journal-title":"Diabetes Care"},{"key":"88593_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jjcc.2010.04.002","volume":"56","author":"DS Sim","year":"2010","unstructured":"Sim, D. S., Jeong, M. H. & Kang, J. C. Current management of acute myocardial infarction: Experience from the Korea Acute Myocardial Infarction Registry. J. Cardiol. 56, 1\u20137 (2010).","journal-title":"J. Cardiol."},{"key":"88593_CR34","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1253\/circj.CJ-16-0061","volume":"80","author":"JH Kim","year":"2016","unstructured":"Kim, J. H. et al. Multicenter cohort study of acute myocardial infarction in Korea\u2014Interim analysis of the korea acute myocardial infarction registry-national institutes of health registry. Circ. J. 80, 1427\u20131436 (2016).","journal-title":"Circ. J."},{"key":"88593_CR35","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1136\/bmj.326.7399.1137","volume":"326","author":"ED Grech","year":"2003","unstructured":"Grech, E. D. ABC of interventional cardiology: Percutaneous coronary intervention. II: The procedure. BMJ 326, 1137\u20131140 (2003).","journal-title":"BMJ"},{"key":"88593_CR36","doi-asserted-by":"publisher","first-page":"e78","DOI":"10.1016\/j.jacc.2012.11.019","volume":"61","author":"PT O'Gara","year":"2013","unstructured":"O\u2019Gara, P. T. et al. 2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: A report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 61, e78\u2013e140 (2013).","journal-title":"J. Am. Coll. Cardiol."},{"key":"88593_CR37","doi-asserted-by":"publisher","first-page":"e139","DOI":"10.1016\/j.jacc.2014.09.017","volume":"64","author":"EA Amsterdam","year":"2014","unstructured":"Amsterdam, E. A. et al. 2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: A report of the American College of Cardiology\/American Heart Association task force on practice guidelines. J. Am. Coll. Cardiol. 64, e139\u2013e228 (2014).","journal-title":"J. Am. Coll. Cardiol."},{"key":"88593_CR38","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1161\/CIRCULATIONAHA.117.029289","volume":"137","author":"HM Garcia-Garcia","year":"2018","unstructured":"Garcia-Garcia, H. M. et al. Standardized end point definitions for coronary intervention trials: The academic research consortium-2 consensus document. Circulation 137, 2635\u20132650 (2018).","journal-title":"Circulation"},{"key":"88593_CR39","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1002\/ccd.27985","volume":"93","author":"YH Kim","year":"2019","unstructured":"Kim, Y. H. et al. Two-year outcomes of statin therapy in patients with acute myocardial infarction with or without dyslipidemia after percutaneous coronary intervention in the era of new-generation drug-eluting stents within Korean population: Data from the Korea Acute Myocardial Infarction Registry. Catheter. Cardiovasc. Interv. 93, 1264\u20131275 (2019).","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"88593_CR40","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s00380-018-1251-0","volume":"34","author":"YH Kim","year":"2019","unstructured":"Kim, Y. H. et al. Two-year clinical outcomes of Zotarolimus- And Everolimus-Eluting Durable-Polymer-Coated Stents Versus Biolimus-Eluting Biodegradable-Polymer-Coated Stent in Patients With Acute Myocardial Infarction With Dyslipidemia After Percutaneous Coronary Intervention: Data From the KAMIR. Heart Vessls. 34, 237\u2013250 (2019).","journal-title":"Heart Vessls."},{"key":"88593_CR41","doi-asserted-by":"publisher","first-page":"e2651","DOI":"10.1097\/MD.0000000000002651","volume":"95","author":"PK Bundhun","year":"2016","unstructured":"Bundhun, P. K., Wu, Z. J. & Chen, M. H. Is there any significant difference in stent thrombosis between sirolimus and paclitaxel eluting stents?: A systematic review and meta-analysis of randomized controlled trials. Medicine (Baltimore) 95, e2651 (2016).","journal-title":"Medicine (Baltimore)"},{"key":"88593_CR42","doi-asserted-by":"publisher","DOI":"10.1177\/2048872620925257","author":"PS Song","year":"2020","unstructured":"Song, P. S. et al. Association of baseline platelet count with all-cause mortality after acute myocardial infarction. Eur. Heart J. Acute Cardiovasc. Care. https:\/\/doi.org\/10.1177\/2048872620925257 (2020).","journal-title":"Eur. Heart J. Acute Cardiovasc. Care."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88593-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88593-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88593-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T02:30:46Z","timestamp":1670034646000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88593-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,30]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["88593"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-88593-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,30]]},"assertion":[{"value":"11 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9364"}}